Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

  • Pharmacy Residency Program

    pharmacy clean room  

    The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related disease.

    The Pharmacy department maintains programs and practices to ensure safe, optimal, and cost effective drug therapy for Dana-Farber patients, while also supporting patient and provider drug education and patient care-oriented research.

    About the Pharmacy Residency Program

    The Pharmacy Residency Program is an ASHP-accredited PGY-2 oncology pharmacy residency designed to provide the resident with opportunities to develop clinical competence in oncology pharmacy practice. Residents are exposed to a multitude of experiences related to cancer care, involving inpatient care at Brigham and Women's Hospital, and ambulatory-related experiences at Dana-Farber Cancer Institute. The resident will gain experience in the following areas of practice:

    • Adult ambulatory oncology
    • Inpatient medical and hematologic oncology
    • Inpatient stem cell transplant
    • Palliative care
    • Pediatric oncology
    • Medication safety
    • Investigational drug services
    • Grand rounds, tumor board, and other oncology related lectures

    Through these educational experiences, residents will:

    1. Demonstrate development as a role-model for clinical pharmacists in the oncology setting.
    2. Develop various teaching styles for application in a variety of settings, including experiential education, small group teaching, and group lecture.
    3. Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
    4. Develop skills in the areas of pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
    5. Refine communication and time management skills.
    6. Develop, implement, and analyze data of a year-long, publishable research project.
    7. Incorporate self-directed learning and personal development through self reflection, evaluation, and feedback.

    Dana-Farber Cancer Institute’s PGY-2 oncology pharmacy residency program gives the residents many opportunities to co-precept and lecture students at the affiliated schools of pharmacy. The residency is primarily affiliated with two schools of pharmacy, including Northeastern School of Pharmacy and Massachusetts College of Pharmacy and Health Sciences University - Boston.

    Research projects

    Research projects will be determined according to the resident's interest and department needs. The resident will be required to complete one project to be presented at a national meeting (HOPA).

    Examples of past resident research projects:

    • 2013-2014
      • Evaluation of off-label oral chemotherapy: A pilot study
      • Off-label use of chemotherapy with limited evidence: An assessment of efficacy and safety
    • 2012-2013
      • Characterization and assessment of anti-cancer therapy used to treat elderly patients with gynecologic malignancies
      • Characteristics of hematopoietic stem cell transplant patients who fall
    • 2011-2012
      • Pharmacist-managed counseling for patients who are discharged after hematopoietic stem cell transplant


    Pharmacy residents will receive a competitive stipend for the PGY-2 residency year. Other benefits include, but are not limited to, medical and dental coverage, and MBTA discount passes.

    In addition, pharmacy residents will be invited to attend professional conferences, including:

    About Dana-Farber Cancer Institute

    Dana-Farber Cancer Institute is a major affiliate of Harvard Medical School that is a designated National Comprehensive Cancer Center (NCCN) by the National Cancer Institute. Dana-Farber partners with Brigham and Women’s Hospital to care for adults with cancer, and partners with Boston Children’s Hospital to provide cancer care for children.

    U.S. News &World Report's Best Hospitals Guide has consistently ranked Dana-Farber/Brigham and Women's Cancer Center the highest in New England for adult cancer care, while Dana-Farber/Boston Children's Cancer and Blood Disorders Center is the nation's #1-ranked pediatric cancer program, according to U.S. News & World Report's 2014-15 Best Children's Hospitals report.

    In addition, the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO), has awarded Dana-Farber Cancer Institute a three-year certification for outpatient hematology-oncology practices that meet its highest standards for quality cancer care.

    Learn more about Dana-Farber’s awards and honors.


    Pharmacy Residency Rotations

    The resident will spend approximately ten months completing core rotations, and is allotted two months for elective experiences and research.

    Core clinical rotations

    • Ambulatory oncology
    • Orientation and training
    • Medical oncology
    • Hematologic oncology
    • Palliative care unit
    • Stem cell transplant
    • Pediatric oncology
    • Investigational drug service

    Longitudinal experiences

    • Medication safety
    • Pharmacy administration
    • Drug information projects
    • Weekly topic discussions
    • Formulary evaluations
    • Drug use evaluations
    • Resident teaching program, if not completed during PGY-1 year
    • Teaching responsibilities at area Schools of Pharmacy
    • Formal and informal education of colleagues in nursing, pharmacy, and medicine

    Elective opportunities

    • Infectious disease
    • Anticoagulation
    • Critical care
    • Hospice
    • Women's oncology
    • Benign hematology
    • Repeat core

    Pharmacy Residency Preceptors

    Residency Director

    Bridget Fowler Scullion, PharmD, BCOP
    Clinical Pharmacy Manager
    Education: St. Louis College of Pharmacy
    PGY-2 Training: University of Maryland, School of Pharmacy, Baltimore, MD


    Sylvia B. Bartel, RPh, MHP
    Vice President of Pharmacy Services
    Education: University of Wisconsin, Madison, WI
    PGY-1 Training: National Institutes of Health, Clinical Center, Bethesda, MD

    Ambulatory Oncology

    Christy S. Harris, PharmD, BCPS, BCOP
    Associate Professor – MCPHS University, Clinical Pharmacy Specialist
    Education: University of Tennessee Health Sciences, Memphis, TN
    PGY-1 Training: University of Tennessee Medical Center, Knoxville, TN
    PGY-2 Training: Medical University of South Carolina, Charleston, SC

    Bone Marrow Transplant / Hematology Malignancies

    Anne McDonnell, PharmD, BCOP
    Inpatient Clinical Pharmacy Specialist
    BS: MCPHS University - Boston
    PharmD: University of Arkansas for Medical Sciences
    PGY-1 Training: New York Presbyterian Hospital, New York, NY
    PGY-2 Training: Medical University of South Carolina, Charleston, SC

    Investigational Drug Services

    Caroline Harvey, RPh
    Research Pharmacy Manager
    Education: Northeastern University, Boston, MA

    Medical Oncology

    Andrew Skirvin, BS, PharmD, BCOP
    Associate Clinical Professor – Northeastern University, Hematology/Oncology Clinical Pharmacist
    Education: University of Texas Health Science Center (PharmD) and Oregon State University (BS)
    PGY-2 Training: Audie L. Murphy Memorial VA Hospital, San Antonio, TX

    Medication Safety

    Audrea Szabatura, PharmD, BCOP
    Medication Safety Officer
    Education: University of Connecticut
    PGY-1 Training: Thomas Jefferson University Hospital, Philadelphia, PA
    PGY-2 Training: The Johns Hopkins Hospital, Baltimore, MD

    Pain and Palliative Care

    Victor Phantumvanit, PharmD, BCPs, BCOP
    Clinical Pharmacy Specialist
    Education: University of Maryland, School of Pharmacy, Baltimore, MD
    PGY-1 Training: Central Washington Hospital, Wenatchee, WA
    PGY-2 Training: Dana-Farber Cancer Institute, Boston, MA


    Theresa LeFrancois, PharmD, BCOP
    Pediatric Oncology Clinical Pharmacist
    Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA


    Current and Past Residents

    Current Residents

    • Doug Hackenyos, PharmD
      PGY-1 Training: Tufts Medical Center, Boston, MA
      Education: MCPHS University - Worcester, MA 
    • Cynthia Herrera, PharmD
      PGY-1 Training: Northwestern Memorial Hospital, Chicago, IL
      Education: Purdue University College of Pharmacy, West Lafayette, IN 

    Past Residents

    • Laura Perry, PharmD
      PGY-1 Training: Dartmouth-Hitchcock Medical Center, Lebanon, NH
      Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
      Current Position: Clinical Dispensing Pharmacist, Dana-Farber Cancer Institute, Boston, MA
    • Taylor Butler, PharmD
      PGY-1 Training: Blout Memorial Hospital, Martville, TN
      Education: The University of Tennessee Health Science Center, Memphis and Knoxville, TN
      Current Position: Assistant Professor, Nova Southeastern University, West Palm Beach, FL
    • Amanda Dietzek, PharmD
      PGY-1 Training: Einstein Medical Center, Philadelphia, PA
      Education: Northeastern University, Boston, MA
      Current Position: Oncology Clinical Pharmacy Manager, Einstein at Center One Pharmacy, Philadelphia, PA
    • Kelly Connelly, PharmD
      PGY-1 Training: The Mount Sinai Medical Center, New York, NY
      Education: Duquesne University, Mylan School of Pharmacy, Pittsburgh, PA
      Current Position: Medical Oncology Pharmacist, Yale New Haven Hospital, New Haven, CT
    • Kelley Carlstrom, PharmD, BCOP
      PGY-1 Training: Beth Israel Deaconess Medical Center, Boston, MA
      Education: University of Colorado, Denver College of Pharmacy, Denver, CO
      Current Position: Hematology/Oncology Clinical Pharmacy Specialist, Cleveland Clinic, Cleveland, OH
    • Meredith W. H. Higley, PharmD, BCPS, BCOP
      PGY-1 Training: Parkview Health, Fort Wayne, IN
      Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
      Current Position: Coordinator, Oncology Pharmacy Services, Berkshire Medical Center, Pittsfield, MA
    • Houry Leblebjian, PharmD, BCOP
      PGY-1 Training: UMass Memorial Medical Center, Worcester, MA
      Education: Lebanese American University, West Beirut, Lebanon
      Current Position: Clinical Pharmacy Specialist, Dana-Farber Cancer Institute, Boston, MA
    • Jian Ni, PharmD
      PGY-1 Training: West Virginia University Hospital, Morgantown, WV
      Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
      Current Position: Hematology/Oncology Pharmacist, Brigham and Women's Hospital, Boston, MA
    • Delila Katz, PharmD, BCOP
      PGY-1 Training: Boston Medical Center, Boston, MA
      Current Position: Clinical Pharmacy Specialist, Palliative Care Oncology, UMass Memorial Medical Center, Worcester, MA
    • Victor Phantumvanit, PharmD, BCPS, BCOP
      PGY-1 Training: Central Washington Hospital, Wenatchee, WA
      Education: University of Maryland, School pf Pharmacy
      Current Position: Clinical Pharmacy Specialist, Dana-Farber Cancer Institute, Boston, MA
    • Gayle Blouin, PharmD, BCOP
      Education: Massachusetts College of Pharmacy and Health Sciences, Boston, MA
      Current Position: Clinical Lead Pharmacist Ambulatory Oncology, Massachusetts General Hospital, Boston, MA

    Applying for the Pharmacy Residency


    Pharm.D degree and ASHP accredited PGY1 pharmacy residency required, with experience in oncology preferred. Candidate must also be eligible for licensure in the Commonwealth of Massachusetts.

    Application procedure

    Please submit your application through PhORCAS —

    • Letter of intent
    • Curriculum vitae
    • Three letters of recommendation

    Deadline for applying: First Friday in January
    Residency start date: First Monday following the 4th of July holiday


    Contact Us

    For more information, please contact:

    Bridget Fowler Scullion, PharmD, BCOP
    Residency Program Director / Clinical Pharmacy Manager 

    Sylvia Bartel, RPh, MHP
    Vice President of Pharmacy 

  •   Email
  •   Print
  •   Share
dana farber logo

450 Brookline Avenue
Boston, MA 02215

Call us toll-free: 866-408-DFCI (3324)

Connect with us

Dana-Farber/Brigham and Women’s Cancer Center is ranked #4 nationally and the best in New England.


Dana-Farber/Boston Children's is ranked the #1 pediatric cancer center.

Sign-up for newsletters